Searched for
HEPATITIS C
AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...- World Hepatitis Day: Know about causes, symptoms and risk factorsJuly 28 is reserved to promote awareness of this insidious and deadly virus.
- 10 Celebrities With Hepatitis C10 Celebrities With Hepatitis C
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Cipla partners with non-profit body FIND to increase detection of Hepatitis CThe organisation works on accelerating development and delivery of affordable diagnostic tests for poverty-related diseases.
- Natco Pharma signs agreement for manufacturing, sale of hepatitis C drugDaclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...
- Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- Strides Shasun gets DCGI nod to manufacture Hepatitis C drugLast year, Strides had entered into a licensing agreement with Gilead Sciences to bring Hepatitis C cure to 91 developing countries.
- Cipla launches generic hepatitis C drug 'Hepcvir-L' in IndiaCipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 t...
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Hepatitis C infection may fuel heart disease riskPeople infected with HIV are already known to have an elevated risk for heart disease but hepatitis C can spark cardiovascular damage indep...
- Roche cuts Hepatitis C drug cost by 65% for government institutionsDrug major Roche has reduced the prices of its Hepatitis C treatment drug 'Exxura' by 65 per cent across all government institutions in Ind...
- Abbott launches Hepatitis C awareness, diagnosis programmeHepatitis C virus causes chronic infection leading to cirrhosis and may cause liver cancer.
- Hepatitis C may increase cancer riskResearchers found that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohor...
- Dr Reddy's shares up on Hepatitis C drug launch planShares of Dr Reddy's Laboratories today settled with gains of nearly 2 per cent after the firm said it is planning to launch Hepatitis C dr...
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Mylan expands pact with Gilead for hepatitis-C drugDrugmaker Mylan Laboratories Ltd said it has expanded its hepatitis C licensing agreement with Gilead Sciences, a US-based biopharma compan...
- Cure for Hepatitis C in HIV patients on the cardsApproximately one-third of HIV patients in the US have hepatitis C, with an estimated 7 million co-infected patients worldwide.
- Key part of hepatitis C virus pictured in great detail: ReportsThe findings can bring an effective hepatitis C vaccine closer to reality.
- 96,000 die every year due to Hepatitis C in India: ReportThe report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
Load More
